Firehawk

DEVICE2 trials

Sponsors

Shanghai MicroPort Medical (Group) Co., Ltd., Duk-Woo Park, MD

Conditions

Coronary Artery DiseaseCoronary DiseaseCoronary Stenosis

Unknown Phase

Randomized MicroPort's Firehawk DES Versus Xience V: TARGET I Trial

CompletedNCT01196819

Shanghai MicroPort Medical (Group) Co., Ltd.Coronary Artery Disease

Start: 2010-09-30End: 2016-12-31Updated: 2019-07-30

IRIS-Firehawk® Cohort in the IRIS-DES Registry

WithdrawnNCT03380286

Duk-Woo Park, MDCoronary Disease, Coronary Stenosis

Start: 2018-03-31End: 2025-12-31Updated: 2018-03-09

Related Papers

[Long term safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent for the treatment of coronary de novo lesions].

PubMed2017-11-243 citations

A randomised comparison of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: clinical and angiographic follow-up of the TARGET I trial.

2013-05-0155 citations